SUBSCRIBE
SUBSCRIBE
News   Drug Development

Antigenics Inc. (New York) Says Cancer Vaccine Study Shows Promise

October 26, 2007 | 
1 min read
Oct 25 (Reuters) - Antigenics Inc (AGEN.O: Quote, Profile, Research) said its potential cancer vaccine Oncophage showed promise in a mid-phase trial on 12 patients.
Clinical research Phase 2
MORE ON THIS TOPIC
Prohibition sign. Halftone hands cross their fingers in a no entry sign. Refusal, stop gesture. Rejection sign. Warning concept. Newspaper collage
FDA
Third FDA Rejection for Aldeyra’s Dry Eye Disease Drug Sends Shares Plummeting
March 17, 2026
 · 
2 min read
 · 
Heather McKenzie
Cambridge, USA - 8 July 2025. Pfizer office entrance with logo on a modern glass building, surrounded by greenery.
Breast cancer
Pfizer’s Ibrance Heir Reduces Risk of Death in Phase 2 Breast Cancer Test
March 17, 2026
 · 
1 min read
 · 
Annalee Armstrong
Abstract creative art collage, market declines in the stock market. The concept of collapse or bankruptcy.
Obesity
Rhythm’s Imcivree Fails Late-Stage Weight Loss Trial in Rare Obesities
March 17, 2026
 · 
2 min read
 · 
Tristan Manalac
Symbolic image: Life as a hurdling - person faces challenges
Insights
AI Drug Discovery Platforms Face New Investor Bar
March 17, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker